Indium In-111 pentetreotide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Octreoscan
Generic Name
Indium In-111 pentetreotide
DrugBank Accession Number
DB11835
Background

Indium In 111 pentetreotide (Octreoscan) has been used in trials studying the diagnostic of SARCOIDOSIS, Solid Tumors, and cushing syndrome.

Type
Small Molecule
Groups
Approved, Investigational
Structure
Thumb
Weight
Average: 1472.41
Monoisotopic: 1471.416070009
Chemical Formula
C62H80InN12O19S2
Synonyms
  • 111In-Pentetreotide
  • Indium (111In) pentetreotide
  • Indium In 111 pentetreotide
  • Indium In 111 Pentreotide
  • Indium In-111 pentetreotide
External IDs
  • MP 1727
  • MP-1727

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
  • Drink plenty of fluids.

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
OctreoscanIndium In-111 pentetreotide (10 ug/1mL) + Indium In-111 chloride (3 mCi/1mL)KitIntravenousCurium US LLC2015-10-14Not applicableUS flag
OctreoscanIndium In-111 pentetreotide (10 ug/1mL) + Indium In-111 chloride (3 mCi/1mL)KitIntravenousMallinckrodt2007-05-012017-07-01US flag

Categories

ATC Codes
V09IB01 — Indium (111in) pentetreotide
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
M312JJ6Z32
CAS number
139096-04-1
InChI Key
ZKZPXKKVDJOAIS-JWFOFJTQSA-J
InChI
InChI=1S/C62H84N12O19S2.In/c1-35(76)47(32-75)69-59(88)49-34-95-94-33-48(70-55(84)44(25-37-13-5-3-6-14-37)65-50(78)29-74(31-52(81)82)24-23-73(30-51(79)80)22-20-41(61(90)91)62(92)93)58(87)67-45(26-38-15-7-4-8-16-38)56(85)68-46(27-39-28-64-42-18-10-9-17-40(39)42)57(86)66-43(19-11-12-21-63)54(83)72-53(36(2)77)60(89)71-49;/h3-10,13-18,28,35-36,41,43-49,53,64,75-77H,11-12,19-27,29-34,63H2,1-2H3,(H,65,78)(H,66,86)(H,67,87)(H,68,85)(H,69,88)(H,70,84)(H,71,89)(H,72,83)(H,79,80)(H,81,82)(H,90,91)(H,92,93);/q;+3/p-4/i;1-4
IUPAC Name
(111In)indium(3+) ion 2-{[2-({[(1-{[10-(4-aminobutyl)-16-benzyl-4-[(1,3-dihydroxybutan-2-yl)-C-hydroxycarbonimidoyl]-6,12,15,18-tetrahydroxy-7-(1-hydroxyethyl)-13-[(1H-indol-3-yl)methyl]-9-oxido-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaen-19-yl]-C-hydroxycarbonimidoyl}-2-phenylethyl)-C-hydroxycarbonimidoyl]methyl}(carboxymethyl)amino)ethyl](3,3-dicarboxypropyl)amino}acetate
SMILES
[111In+3].CC(O)C(CO)N=C(O)C1CSSCC(N=C(O)C(CC2=CC=CC=C2)N=C([O-])CN(CCN(CCC(C(O)=O)C(O)=O)CC([O-])=O)CC([O-])=O)C(O)=NC(CC2=CC=CC=C2)C(O)=NC(CC2=CNC3=CC=CC=C23)C(O)=NC(CCCCN)C([O-])=NC(C(C)O)C(O)=N1

References

General References
Not Available
PubChem Compound
131704321
PubChem Substance
347828180
RxNav
1724429

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4TerminatedDiagnosticTumors, Solid1
1, 2TerminatedDiagnosticGastroenteropancreatic Neuroendocrine Tumors1
Not AvailableCompletedDiagnosticSarcoidosis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, powder, for solutionIntravenous
KitIntravenous
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)Region
US6123916No2000-09-262017-09-26US flag
US5776894No1998-07-072015-07-07US flag

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0217 mg/mLALOGPS
logP1.24ALOGPS
logP3.79ChemAxon
logS-4.9ALOGPS
pKa (Strongest Acidic)2.08ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count30ChemAxon
Hydrogen Donor Count13ChemAxon
Polar Surface Area530.22 Å2ChemAxon
Rotatable Bond Count32ChemAxon
Refractivity391.61 m3·mol-1ChemAxon
Polarizability136.16 Å3ChemAxon
Number of Rings5ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on October 20, 2016 20:52 / Updated on November 03, 2020 01:20